The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily
In: Journal of human hypertension, Jg. 23 (2009-01-17), Heft 8
Online
unknown
Zugriff:
The objective of this Phase III double-blind parallel-group controlled study was to examine the superiority of amlodipine 10 mg once daily (the amlodipine 10 mg group) to amlodipine 5 mg once daily (the amlodipine 5 mg group) in 305 Japanese outpatients with essential hypertension whose systolic blood pressure (SBP) had not reached the therapeutic target levels (
Titel: |
The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily
|
---|---|
Autor/in / Beteiligte Person: | Fujiwara, T ; Ii, Y ; Hatsuzawa, J ; Murase, H ; Watanabe, T ; Murakami, M ; Kimura, N ; Buch, J ; Tsuchihashi, T ; Saruta, T |
Link: | |
Zeitschrift: | Journal of human hypertension, Jg. 23 (2009-01-17), Heft 8 |
Veröffentlichung: | 2009 |
Medientyp: | unknown |
ISSN: | 1476-5527 (print) |
Schlagwort: |
|
Sonstiges: |
|